VIVIMEDLAB.NSVIVIMEDLAB.NSNSE
Loading
Year-over-year earnings per share growth rate
Percentile
P33
Within normal range
vs 3Y Ago
-44.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -33.33% |
| Q2 2025 | 1.49% |
| Q1 2025 | 6.94% |
| Q4 2024 | -16.13% |
| Q3 2024 | 66.30% |
| Q2 2024 | -392.06% |
| Q1 2024 | 132.47% |
| Q4 2023 | 20.82% |
| Q3 2023 | -30.32% |
| Q2 2023 | 94.14% |
| Q1 2023 | -1351.58% |
| Q4 2022 | 16.92% |
| Q3 2022 | 0.75% |
| Q2 2022 | -21.27% |
| Q1 2022 | 22.73% |
| Q4 2021 | -1.78% |
| Q3 2021 | -903.57% |
| Q2 2021 | 91.54% |
| Q1 2021 | 44.65% |
| Q4 2020 | -264.63% |
| Q3 2020 | -205.81% |
| Q2 2020 | 121.12% |
| Q1 2020 | -89.66% |
| Q4 2019 | -21.70% |
| Q3 2019 | -360.66% |
| Q2 2019 | 4568.86% |
| Q1 2019 | -102.08% |
| Q4 2018 | -40.72% |
| Q3 2018 | -35.94% |
| Q2 2018 | 219.44% |
| Q1 2018 | -57.31% |
| Q4 2017 | -5.95% |
| Q3 2017 | -7.24% |
| Q2 2017 | -77.62% |
| Q1 2017 | 103.13% |
| Q4 2016 | 92.75% |
| Q3 2016 | -1.78% |
| Q2 2016 | -56.68% |
| Q1 2016 | 173.94% |
| Q4 2015 | -3.73% |